2023 Q1 Form 10-K Financial Statement

#000121390023025410 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $408.6K $375.9K $2.860M
YoY Change -56.02% -42.12% 68.21%
Cost Of Revenue $412.0K $501.4K $2.551M
YoY Change -32.69% 17.09% 124.71%
Gross Profit -$3.362K -$125.4K $309.0K
YoY Change -101.06% -156.7% -45.31%
Gross Profit Margin -0.82% -33.37% 10.8%
Selling, General & Admin $1.673M $3.682M $11.49M
YoY Change -63.7% 75.94% 9.1%
% of Gross Profit 3718.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $3.990K
YoY Change -100.0% -100.0% 748.94%
% of Gross Profit 1.29%
Operating Expenses $1.673M $3.682M $11.49M
YoY Change -63.7% 75.94% 9.1%
Operating Profit -$2.012M -$3.807M -$15.23M
YoY Change -53.11% 103.45% 52.85%
Interest Expense $120.0K $15.90K
YoY Change 500.0% -28.57%
% of Operating Profit
Other Income/Expense, Net $1.226K $9.690K $99.91K
YoY Change -72.57% 3776.0% 10878.68%
Pretax Income -$2.011M -$3.797M -$15.20M
YoY Change -53.09% 102.96% 52.55%
Income Tax
% Of Pretax Income
Net Earnings -$2.011M -$3.797M -$15.20M
YoY Change -53.09% 102.96% 52.55%
Net Earnings / Revenue -492.09% -1010.14% -531.56%
Basic Earnings Per Share -$0.15 -$1.21
Diluted Earnings Per Share -$0.15 -$0.30 -$1.21
COMMON SHARES
Basic Shares Outstanding 15.88M shares 12.73M shares 12.55M shares
Diluted Shares Outstanding 13.33M shares 12.55M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.604M $2.080M $2.080M
YoY Change -76.65% -87.05% -87.05%
Cash & Equivalents $2.604M $2.080M
Short-Term Investments
Other Short-Term Assets $1.038M $1.030M $1.030M
YoY Change -17.08% 162.15% 162.15%
Inventory $3.468M $3.696M $3.696M
Prepaid Expenses $313.0K
Receivables $230.2K $259.3K $259.3K
Other Receivables $22.74K $842.6K
Total Short-Term Assets $7.362M $7.908M $7.908M
YoY Change -53.45% -56.69% -56.69%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $0.00
YoY Change -100.0%
Long-Term Investments
YoY Change
Other Assets $599.9K $678.2K $678.2K
YoY Change -34.29% -31.58% -31.58%
Total Long-Term Assets $599.9K $678.2K $678.2K
YoY Change -34.56% -31.85% -31.85%
TOTAL ASSETS
Total Short-Term Assets $7.362M $7.908M $7.908M
Total Long-Term Assets $599.9K $678.2K $678.2K
Total Assets $7.962M $8.586M $8.586M
YoY Change -52.41% -55.4% -55.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $777.3K $589.2K $1.839M
YoY Change 30.47% 41.39% 341.35%
Accrued Expenses $526.4K $422.9K $1.123M
YoY Change -58.67% 98.68% -3.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.555M $2.973M $2.973M
YoY Change -26.55% 36.56% 36.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.555M $2.973M $2.973M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.555M $2.973M $2.973M
YoY Change -26.55% 36.56% 36.56%
SHAREHOLDERS EQUITY
Retained Earnings -$17.83M -$15.82M
YoY Change 2462.54%
Common Stock $15.88K $12.73K
YoY Change 4.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.407M $5.614M $5.614M
YoY Change
Total Liabilities & Shareholders Equity $7.962M $8.586M $8.586M
YoY Change -52.41% -55.4% -55.4%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$2.011M -$3.797M -$15.20M
YoY Change -53.09% 102.96% 52.55%
Depreciation, Depletion And Amortization $0.00 $0.00 $3.990K
YoY Change -100.0% -100.0% 748.94%
Cash From Operating Activities -$2.092M -$1.267M -$13.53M
YoY Change -53.95% -66.47% 133.65%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions $400.0K
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.615M -68.29K -$455.4K
YoY Change -805.16% -100.35% -102.08%
NET CHANGE
Cash From Operating Activities -$2.092M -1.267M -$13.53M
Cash From Investing Activities 0.000
Cash From Financing Activities $2.615M -68.29K -$455.4K
Net Change In Cash $523.2K -1.335M -$13.98M
YoY Change -110.65% -108.43% -187.07%
FREE CASH FLOW
Cash From Operating Activities -$2.092M -$1.267M -$13.53M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$1.267M -$13.53M
YoY Change -66.47% 133.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41147
CY2022 dei Entity Registrant Name
EntityRegistrantName
FRESH VINE WINE, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3905007
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
11500 Wayzata Blvd.
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
#1147
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Minnetonka
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55305
CY2022 dei City Area Code
CityAreaCode
(855)
CY2022 dei Local Phone Number
LocalPhoneNumber
766-9463
CY2022 dei Security12b Title
Security12bTitle
Common stock, $0.001 par value
CY2022 dei Trading Symbol
TradingSymbol
VINE
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
13373651.1 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15876227 shares
CY2022 dei Auditor Name
AuditorName
Wipfli LLP
CY2022 dei Auditor Location
AuditorLocation
Minneapolis, Minnesota
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2080335 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16063941 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
259317 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
208160 usd
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
153075 usd
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
146314 usd
CY2021Q4 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
376000 usd
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
37733 usd
CY2022Q4 vine Insurance Recovery Receivable
InsuranceRecoveryReceivable
804907 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
3696198 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
159060 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
961211 usd
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
1150987 usd
CY2022Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
68286 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
7907987 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
18257537 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
678167 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
991167 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3990 usd
CY2022Q4 us-gaap Assets
Assets
8586154 usd
CY2021Q4 us-gaap Assets
Assets
19252694 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
589204 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
416716 usd
CY2022Q4 vine Accrued Compensation
AccruedCompensation
420413 usd
CY2021Q4 vine Accrued Compensation
AccruedCompensation
416414 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1250000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
422931 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
212866 usd
CY2022Q4 vine Accrued Expenses Related Parties
AccruedExpensesRelatedParties
280000 usd
CY2021Q4 vine Accrued Expenses Related Parties
AccruedExpensesRelatedParties
529617 usd
CY2021Q4 vine Secured Borrowings
SecuredBorrowings
171069 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10000 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13750 usd
CY2021Q4 vine Promissory Note Related Party
PromissoryNoteRelatedParty
216000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
200272 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2972548 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2176074 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2972548 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2176074 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12732257 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12732257 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12200013 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12200013 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12732 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12200 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21420732 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17681141 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15819858 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-617351 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5613606 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
17075990 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8586154 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19252694 usd
CY2022 vine Wholesale Revenue
WholesaleRevenue
1651451 usd
CY2021 vine Wholesale Revenue
WholesaleRevenue
772711 usd
CY2022 us-gaap Direct Financing Lease Revenue
DirectFinancingLeaseRevenue
911326 usd
CY2021 us-gaap Direct Financing Lease Revenue
DirectFinancingLeaseRevenue
774421 usd
CY2022 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
297224 usd
CY2021 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
153075 usd
CY2022 us-gaap Revenues
Revenues
2860001 usd
CY2021 us-gaap Revenues
Revenues
1700207 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
2551009 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
1135268 usd
CY2022 us-gaap Gross Profit
GrossProfit
308992 usd
CY2021 us-gaap Gross Profit
GrossProfit
564939 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11489804 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4793445 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
4053123 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
5738029 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-15233936 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-9966535 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
31429 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
908 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-15202507 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-9965627 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12550096 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8870902 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12550096 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8870902 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.21
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.12
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.21
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.12
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1463158 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2309852 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7042196 usd
CY2021 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
1760000 usd
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1087273 usd
CY2021 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
19152727 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-9965627 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
17075990 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2506823 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1233300 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-15202507 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5613606 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-15202507 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-9965627 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
3990 usd
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
472 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
4053123 usd
CY2021 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
5738029 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
51157 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
195008 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-153075 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
153075 usd
CY2022 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
804907 usd
CY2022 vine Increase Decreasein Receivables With Recourse
increaseDecreaseinReceivablesWithRecourse
-146314 usd
CY2021 vine Increase Decreasein Receivables With Recourse
increaseDecreaseinReceivablesWithRecourse
146314 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-376000 usd
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
303477 usd
CY2022 vine Increase Decrease In Due From Employee
IncreaseDecreaseInDueFromEmployee
37733 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3537138 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5510 usd
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-189776 usd
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
765996 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
172488 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
347847 usd
CY2022 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
3999 usd
CY2021 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
416414 usd
CY2022 vine Increase Decreasein Accrued Expenses Settlement
IncreaseDecreaseinAccruedExpensesSettlement
1250000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
210065 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
212866 usd
CY2022 vine Increase Decrease In Accrued Expenses Related Parties
IncreaseDecreaseInAccruedExpensesRelatedParties
249617 usd
CY2021 vine Increase Decrease In Accrued Expenses Related Parties
IncreaseDecreaseInAccruedExpensesRelatedParties
-529617 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-3750 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
13750 usd
CY2022 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
-200272 usd
CY2021 us-gaap Increase Decrease In Due To Other Related Parties
IncreaseDecreaseInDueToOtherRelatedParties
-1524950 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13528251 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5789942 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
250 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-250 usd
CY2021 us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
432000 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
216000 usd
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
216000 usd
CY2022 vine Payments Of Issuance Outstanding Secured Borrowings
PaymentsOfIssuanceOutstandingSecuredBorrowings
-171069 usd
CY2021 vine Payments Of Issuance Outstanding Secured Borrowings
PaymentsOfIssuanceOutstandingSecuredBorrowings
171069 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2309852 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
68286 usd
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
19152727 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-455355 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21849648 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13983606 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16059456 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16063941 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4485 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2080335 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16063941 usd
CY2021 us-gaap Stock Issued1
StockIssued1
1565000 usd
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
1.68 pure
CY2021Q4 us-gaap Debt Instrument Convertible Conversion Ratio1
DebtInstrumentConvertibleConversionRatio1
6.1934 pure
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022 vine Related Party Service
RelatedPartyService
0.104 pure
CY2021 vine Related Party Service
RelatedPartyService
0.091 pure
CY2022 vine Total Revenue
TotalRevenue
1 pure
CY2021 vine Total Revenue
TotalRevenue
1 pure
CY2021Q4 us-gaap Proceeds From Fees Received
ProceedsFromFeesReceived
19200000 usd
CY2021Q4 us-gaap Other Underwriting Expense
OtherUnderwritingExpense
1800000 usd
CY2021Q4 vine Offering Expenses
OfferingExpenses
1100000 usd
CY2021Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
12200013 shares
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><i><span style="text-decoration:underline">Accounting Estimates</span></i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Management uses estimates and assumptions in preparing these financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include allowance for doubtful accounts, allowance for inventory obsolescence, equity-based compensation for employees and non-employees, and the valuation of deferred tax assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 7pt"> </span></p>
CY2022 vine Wholesale
Wholesale
0.577 pure
CY2021 vine Wholesale
Wholesale
0.454 pure
CY2022 vine Direct To Consumer
DirectToConsumer
0.319 pure
CY2021 vine Direct To Consumer
DirectToConsumer
0.455 pure
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3990 usd
CY2022Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
10000 usd
CY2021Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
13750 usd
CY2020Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
0 usd
CY2022 us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
13750 usd
CY2021 us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
0 usd
CY2022 vine Accrued Equity Based Compensation
AccruedEquityBasedCompensation
259317 usd
CY2021 vine Accrued Equity Based Compensation
AccruedEquityBasedCompensation
208160 usd
CY2020 vine Accrued Equity Based Compensation
AccruedEquityBasedCompensation
13152 usd
CY2022Q4 us-gaap Defined Benefit Plan Funded Percentage
DefinedBenefitPlanFundedPercentage
0.50 pure
CY2022Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
991167 usd
CY2021Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
1304167 usd
CY2022 us-gaap Advertising Expense
AdvertisingExpense
3059429 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
1873479 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12550096 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8870902 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12550096 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8870902 shares
CY2022 vine Weighted Average Units Outstanding
WeightedAverageUnitsOutstanding
2721562 shares
CY2021 vine Weighted Average Units Outstanding
WeightedAverageUnitsOutstanding
2744778 shares
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3683159 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
137647 usd
CY2022Q4 us-gaap Retail Related Inventory Merchandise
RetailRelatedInventoryMerchandise
13039 usd
CY2021Q4 us-gaap Retail Related Inventory Merchandise
RetailRelatedInventoryMerchandise
21413 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
3696198 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
159060 usd
CY2021 vine Prepaidlicenseandfees
Prepaidlicenseandfees
3395 usd
CY2022 us-gaap Marketing Expense
MarketingExpense
313000 usd
CY2021 us-gaap Marketing Expense
MarketingExpense
313000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
678167 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
991167 usd
CY2022Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
569377 usd
CY2021Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
758250 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
78834 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
76313 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1639378 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2142155 usd
CY2022 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2022Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
3990 usd
CY2021Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
4788 usd
CY2022Q4 us-gaap Accumulated Amortization Of Other Deferred Costs
AccumulatedAmortizationOfOtherDeferredCosts
3990 usd
CY2021Q4 us-gaap Accumulated Amortization Of Other Deferred Costs
AccumulatedAmortizationOfOtherDeferredCosts
798 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3990 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
3990 usd
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
472 usd
CY2021Q4 vine Orders Not Yet Shipped
OrdersNotYetShipped
4099 usd
CY2022Q4 vine Direct To Consumer Prepayments
DirectToConsumerPrepayments
10000 usd
CY2021Q4 vine Direct To Consumer Prepayments
DirectToConsumerPrepayments
9651 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
10000 usd
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
13750 usd
CY2022Q4 vine Accured Compensation
AccuredCompensation
420413 usd
CY2021Q4 vine Accured Compensation
AccuredCompensation
416414 usd
CY2022Q4 vine Sponsorship Agreements
SponsorshipAgreements
-234494 usd
CY2021Q4 vine Sponsorship Agreements
SponsorshipAgreements
-80000 usd
CY2022Q4 vine Accrued Credit Card Charges
AccruedCreditCardCharges
-21013 usd
CY2021Q4 vine Accrued Credit Card Charges
AccruedCreditCardCharges
-39563 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
167424 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
93303 usd
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
422931 usd
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
212866 usd
CY2021Q1 vine Percentage Of Pay Off A Member Loan
PercentageOfPayOffAMemberLoan
0.50 pure
CY2021Q1 vine Percentage Of Proportion Interests
PercentageOfProportionInterests
0.50 pure
CY2022 vine Percentage Of Vest
PercentageOfVest
0.25 pure
CY2022 vine Percentage Of Vest Additional Three Year Period
PercentageOfVestAdditionalThreeYearPeriod
0.75 pure
CY2021Q4 us-gaap Derivative Forward Exchange Rate1
DerivativeForwardExchangeRate1
6.1934 pure
CY2021Q4 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
1 shares
CY2021Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
1614615 shares
CY2021Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
1614615 shares
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
10000013 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
25000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
12200013 shares
CY2022 us-gaap Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares
StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares
970000 shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1030000 shares
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1233300 usd
CY2021Q1 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
140300 shares
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
4902802 usd
CY2021Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
5000000 usd
CY2022 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
991167 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
313000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
313000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
313000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
52167 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
991167 usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1658485 usd
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
171216 usd
CY2022Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
47800 shares
CY2022 us-gaap Restricted Stock Expense
RestrictedStockExpense
219648 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
377777 shares
CY2021 vine Weighted Average Remaining Contractual Term Years Granted
WeightedAverageRemainingContractualTermYearsGranted
P0Y5M12D
CY2021Q4 vine Share Based Compensation Arrangement By Shares Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementBySharesBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
377777 shares
CY2021 vine Weighted Averages Remaining Outstanding Ending Balance
WeightedAveragesRemainingOutstandingEndingBalance
P0Y5M12D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
117800 shares
CY2022 vine Weighted Average Remaining Contractual Term Years Granted
WeightedAverageRemainingContractualTermYearsGranted
P0Y3M29D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
495577 shares
CY2022 vine Vested Shares
VestedShares
3334 shares
CY2022 vine Shares Schedule
SharesSchedule
6666 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
6666 shares
CY2022Q2 vine Unvested Restricted Stock
UnvestedRestrictedStock
66666 usd
CY2022 vine Equity Based Compensation Expense
EquityBasedCompensationExpense
110602 usd
CY2022 vine Number Of Shares Of Restricted Stock Granted
NumberOfSharesOfRestrictedStockGranted
110000 shares
CY2022 vine Weighted Average Remaining Contractual Term Year Granted
WeightedAverageRemainingContractualTermYearGranted
P9Y3M7D
CY2022 vine Number Of Shares Of Restricted Stock Vested Or Released
NumberOfSharesOfRestrictedStockVestedOrReleased
-36668 shares
CY2022 vine Number Of Shares Of Restricted Stock Forfeited
NumberOfSharesOfRestrictedStockForfeited
-66667 shares
CY2022 vine Weighted Averages Remaining Contractual Term Years Forfeited
WeightedAveragesRemainingContractualTermYearsForfeited
P9Y3M
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6666 shares
CY2022 vine Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerm
P9Y4M28D
CY2022Q1 vine Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableTerm
P10Y
CY2022Q1 vine Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableTerm
P10Y
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
41449 usd
CY2022 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
0.15 pure
CY2022 vine Options Installments Percentage
OptionsInstallmentsPercentage
0.20 pure
CY2021Q4 vine Warrants Purchase Shares
WarrantsPurchaseShares
110000 shares
CY2021Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
12
CY2021Q4 vine Warrants Vest Year
WarrantsVestYear
P1Y
CY2021Q4 vine Exercisable Vest Years
ExercisableVestYears
P4Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.75 pure
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3193000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2093003 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-162000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.011 pure
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-14000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.001 pure
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3355000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.221 pure
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
519000 usd
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.052 pure
CY2022 vine Effective Income Percentage Conversion From Llc To C Corporation
EffectiveIncomePercentageConversionFromLLCToCCorporation
0 pure
CY2021 vine Effective Income Conversion From Llc To C Corporation
EffectiveIncomeConversionFromLLCToCCorporation
1588000 usd
CY2021 vine Effective Income Percentage Conversion From Llc To C Corporation
EffectiveIncomePercentageConversionFromLLCToCCorporation
-0.159 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
234000 usd
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
3000 usd
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
3000 usd
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
868000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
45000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3002000 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
237000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3874000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
519000 usd
CY2022 us-gaap Federal State And Local Income Tax Expense Benefit Continuing Operations
FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations
13.3 usd
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
2.2 usd
CY2021 us-gaap Federal State And Local Income Tax Expense Benefit Continuing Operations
FederalStateAndLocalIncomeTaxExpenseBenefitContinuingOperations
1000000 usd
CY2021 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
300000 usd
CY2022 vine Purchases Finished Goods
PurchasesFinishedGoods
0.20 pure
CY2022 vine Inventory Purchases Percentage
InventoryPurchasesPercentage
0.96 pure
CY2021 vine Inventory Purchases Percentage
InventoryPurchasesPercentage
0.90 pure
CY2022 vine Number Of Customers Operates In Several Markets
NumberOfCustomersOperatesInSeveralMarkets
2 pure
CY2022 vine Percentage Of Wholesale Revenue
PercentageOfWholesaleRevenue
0.58 pure
CY2021 vine Percentage Of Wholesale Revenue
PercentageOfWholesaleRevenue
0.45 pure
CY2021Q4 vine Percentage Of Customers Accounted
PercentageOfCustomersAccounted
0.61 pure
CY2021Q1 us-gaap Impairment Of Ongoing Project
ImpairmentOfOngoingProject
300000 usd
CY2021Q1 vine Initial Serive Term
InitialSeriveTerm
P5Y
CY2021Q4 vine Investor Options To Terminate Agreements
InvestorOptionsToTerminateAgreements
5000000 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
380000 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
500000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022Q4 vine Operating Leases Future Minimum Payment Due Current
OperatingLeasesFutureMinimumPaymentDueCurrent
480000 usd
CY2022Q4 vine Operating Leases Future Minimum Payment Due In Two Years
OperatingLeasesFutureMinimumPaymentDueInTwoYears
480000 usd
CY2022Q4 vine Operating Leases Future Minimum Payment Due In Three Years
OperatingLeasesFutureMinimumPaymentDueInThreeYears
480000 usd
CY2022Q4 vine Operating Leases Future Minimum Payment Due In Four Years
OperatingLeasesFutureMinimumPaymentDueInFourYears
80000 usd
CY2022Q4 vine Operating Leases Future Minimum Payment Due
OperatingLeasesFutureMinimumPaymentDue
1520000 usd
CY2021Q3 vine Initial Serive Term
InitialSeriveTerm
P1Y
CY2022Q4 us-gaap Secured Borrowings Gross Difference Amount
SecuredBorrowingsGrossDifferenceAmount
0 usd
CY2021Q4 us-gaap Secured Borrowings Gross Difference Amount
SecuredBorrowingsGrossDifferenceAmount
171069 usd
CY2022 us-gaap Interest Expense
InterestExpense
15898 usd
CY2021 us-gaap Interest Expense
InterestExpense
22256 usd
CY2022 vine Consulting Agreement Description
ConsultingAgreementDescription
The Company had an arrangement with Rabbit Hole Equity, LLC (RHE), a related party due to common ownership, under which RHE provided development, administrative and financial services to the Company.
CY2021 us-gaap Salaries And Wages
SalariesAndWages
1598655 usd
CY2022 us-gaap Payments For Rent
PaymentsForRent
94436 usd
CY2021 us-gaap Payments For Rent
PaymentsForRent
81050 usd
CY2022Q4 us-gaap Accrued Utilities Current
AccruedUtilitiesCurrent
5470 usd
CY2021Q4 us-gaap Accrued Utilities Current
AccruedUtilitiesCurrent
3950 usd
CY2022 us-gaap Other Expenses
OtherExpenses
99906 usd
CY2021 us-gaap Other Expenses
OtherExpenses
1683655 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
200272 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
376000 usd
CY2021 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
9125 usd
CY2021Q4 us-gaap Management Fee Expense
ManagementFeeExpense
50000 usd
CY2022 us-gaap Insurance Services Revenue
InsuranceServicesRevenue
297224 usd
CY2021 us-gaap Insurance Services Revenue
InsuranceServicesRevenue
153075 usd
CY2022 vine Inventory Purchased
InventoryPurchased
195116 usd
CY2022Q1 vine Consulting Agreement Description
ConsultingAgreementDescription
the Company entered into a consulting agreement with FELCS, LLC, an entity owned by Damian Novak to provide consulting and advisory services to the Company in exchange for $25,000 per month.
CY2022 vine Total Expense
TotalExpense
275000 usd
CY2022Q2 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
5000 usd
CY2022 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
90000 usd
CY2021 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
60000 usd
CY2022 vine Expiration Date
ExpirationDate
P5Y
CY2022 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
1.25
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3143969 shares
CY2023Q1 vine Gross Proceeds
GrossProceeds
3140000 usd
CY2023Q1 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
2700000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
3930000 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
usd
CY2021Q4 vine Insurance Recovery Receivable
InsuranceRecoveryReceivable
usd
CY2021Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
usd
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
usd
CY2022Q4 vine Secured Borrowings
SecuredBorrowings
usd
CY2022Q4 vine Promissory Note Related Party
PromissoryNoteRelatedParty
usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
CY2021 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
usd
CY2021 vine Increase Decrease In Due From Employee
IncreaseDecreaseInDueFromEmployee
usd
CY2021 vine Increase Decreasein Accrued Expenses Settlement
IncreaseDecreaseinAccruedExpensesSettlement
usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2022 us-gaap Stock Issued1
StockIssued1
usd
CY2022 vine Dilutive Effect Of Shares Authorized
DilutiveEffectOfSharesAuthorized
CY2021 vine Dilutive Effect Of Shares Authorized
DilutiveEffectOfSharesAuthorized
CY2022 vine Prepaidlicenseandfees
Prepaidlicenseandfees
usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
usd
CY2022Q4 vine Orders Not Yet Shipped
OrdersNotYetShipped
usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2021 vine Weighted Average Remaining Contractual Term Years Forfeited
WeightedAverageRemainingContractualTermYearsForfeited
CY2022 vine Weighted Average Remaining Contractual Term Year Vested Or Released
WeightedAverageRemainingContractualTermYearVestedOrReleased
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2022 vine Weighted Average Remaining Contractual Term Years Forfeited
WeightedAverageRemainingContractualTermYearsForfeited
CY2022Q4 vine Share Based Compensation Arrangement By Shares Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementBySharesBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2022 vine Weighted Averages Remaining Outstanding Ending Balance
WeightedAveragesRemainingOutstandingEndingBalance
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
CY2022 vine Weighted Average Remaining Contractual Term Years Vested Or Released
WeightedAverageRemainingContractualTermYearsVestedOrReleased
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 vine Effective Income Conversion From Llc To C Corporation
EffectiveIncomeConversionFromLLCToCCorporation
usd
CY2022 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
usd
CY2021 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 us-gaap Salaries And Wages
SalariesAndWages
usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
usd
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001880343

Files In Submission

Name View Source Status
0001213900-23-025410-index-headers.html Edgar Link pending
0001213900-23-025410-index.html Edgar Link pending
0001213900-23-025410.txt Edgar Link pending
0001213900-23-025410-xbrl.zip Edgar Link pending
ex10-31_001.jpg Edgar Link pending
f10k2022ex10-31_freshvine.htm Edgar Link pending
f10k2022ex23-1_freshvine.htm Edgar Link pending
f10k2022ex31-1_freshvine.htm Edgar Link pending
f10k2022ex31-2_freshvine.htm Edgar Link pending
f10k2022ex32-1_freshvine.htm Edgar Link pending
f10k2022_freshvine.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
f10k2022_freshvine_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vine-20221231.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
vine-20221231_cal.xml Edgar Link unprocessable
vine-20221231_def.xml Edgar Link unprocessable
vine-20221231_pre.xml Edgar Link unprocessable
vine-20221231_lab.xml Edgar Link unprocessable